| Argentina |
1 report/1 case |
Mild |
0 |
| Austria |
1 report/1 case |
Mild |
0 |
| Korea |
1 report/1 case |
Mild |
0 |
| Morocco |
1 report/1 case |
Mild |
0 |
| Uganda |
1 report/1 case |
Mild |
0 |
| Peru |
1 report/1 case |
Severe |
1 |
| Libya |
1 report/1 case |
Severe |
1 |
| Panama |
1 report/2 cases |
50% Mild; 50% Severe |
0 |
| Singapore |
2 reports/2 cases |
50% Mild; 50% Severe |
0 |
| Nigeria |
1 report/4 cases |
100% Mild |
0 |
| Turkey |
1 report/4 cases |
25% Critical; 75% Mild |
1 |
| Japan |
2 reports/6 cases |
100% Mild |
0 |
| India |
2 reports/8 cases |
87.5% Mild; 12.5% Asymptomatic |
0 |
| Brazil |
4 reports/12 cases |
42% Mild; 58.3% Severe |
2 |
| France |
1 report/30 cases |
90% Mild; 10% Severe |
2 |
| Germany |
1 report/33 cases |
76% Mild; 24% Severe/Critical |
3 |
| Belgium |
1 report/101 cases |
21% Asymptomatic; 15% Severe |
9 |
| China |
14 reports/138 cases |
52.2% Severe |
8 |
| Italy |
9 reports/321 cases |
23%Severe/Critical; 73% Mild; 4% Asymptomatic |
13 |
| Spain |
5 reports/408 cases |
44.9% Severe/Critical; 55% Mild |
22 |
| South Africa |
4 reports/4004 cases |
3.04% Severe/Critical |
122 |
| United States of America |
28 reports/6712 cases |
12.6% Severe/Critical |
710 |
| United Kingdom |
8 reports/27688 cases |
0.4% Severe |
59 |